Valuation: Sanofi

Market Cap 95.53B 107B 87.88B 79.62B 149B 10,128B 152B 1,048B 421B 5,328B 400B 392B 16,802B P/E 2026 *
12.7x
P/E 2027 * 11x
Enterprise Value 107B 119B 98.14B 88.92B 166B 11,311B 169B 1,170B 470B 5,950B 447B 438B 18,764B EV / Sales 2026 *
2.24x
EV / Sales 2027 * 2.04x
Free-Float
88.34%
Yield 2026 *
5.35%
Yield 2027 * 5.66%
1 day+4.71%
1 week+7.58%
Current month+9.77%
1 month+9.77%
3 months+9.58%
6 months-0.10%
Current year-3.60%
1 week 74.25
Extreme 74.25
81.19
1 month 69.75
Extreme 69.75
81.19
Current year 69.75
Extreme 69.75
84.97
1 year 69.75
Extreme 69.75
90.79
3 years 69.75
Extreme 69.75
110.88
5 years 69.75
Extreme 69.75
110.88
10 years 62.88
Extreme 62.88
110.88
Manager TitleAgeSince
Chief Executive Officer 65 2026-04-30
Director of Finance/CFO 64 2024-03-31
Chief Tech/Sci/R&D Officer - 2026-08-31
Director TitleAgeSince
Director/Board Member 61 2019-04-29
Director/Board Member 56 2020-04-27
Director/Board Member 65 2020-04-27
Date Insider Type Main position Quantity % Market Cap. Importance
8/20/26 Buy

Chief Executive Officer

1,506 0.0001%
8/20/26 Buy

Head of Human Resources

54 0.0000%
8/20/26 Buy

Executive/Senior Manager

840 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+4.71%+7.58%-9.46%-5.23% 107B
+3.19%+11.31%+67.86%+150.58% 1,263B
-0.73%+3.56%+44.51%+85.81% 658B
+1.41%+3.24%+29.22%+107.83% 521B
+0.42%+3.20%+54.15%+67.18% 391B
+2.18%+2.93%+73.30%+45.62% 369B
+1.12%+4.52%+35.30%+58.08% 307B
+6.96%+8.86%+11.27%+36.62% 290B
+1.15%+6.09%+59.59%+77.06% 252B
+3.06%+9.38%+44.11%+119.47% 212B
Average +2.03%+6.07%+40.98%+74.30% 436.86B
Weighted average by Cap. +1.28%+6.62%+49.41%+95.79%

Financials

2026 *2027 *
Net sales 47.6B 53.15B 43.78B 39.67B 74.16B 5,046B 75.54B 522B 210B 2,655B 199B 195B 8,372B 50.7B 56.61B 46.64B 42.26B 78.99B 5,376B 80.47B 556B 223B 2,828B 212B 208B 8,918B
Net income 7.69B 8.59B 7.07B 6.41B 11.98B 815B 12.21B 84.36B 33.86B 429B 32.23B 31.54B 1,353B 9.1B 10.16B 8.37B 7.58B 14.17B 965B 14.44B 99.8B 40.06B 507B 38.13B 37.32B 1,600B
Net Debt 11.15B 12.45B 10.26B 9.3B 17.38B 1,182B 17.7B 122B 49.11B 622B 46.74B 45.74B 1,962B 7.68B 8.58B 7.07B 6.4B 11.97B 814B 12.19B 84.27B 33.83B 428B 32.19B 31.51B 1,351B
Projected Income Statement - Annual - Sanofi
Logo Sanofi
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (81.8%): prescription drugs for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases; - human vaccines (18.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas. At the end of 2025, the group had 37 production sites worldwide. Net sales are distributed geographically as follows: France (3.9%), Europe (17.1%), the United States (50.8%), China (6%) and other (22.2%).
Employees
74,846
Date Price Change Volume
26-10-30 €79.74 +4.71% 8,149,616
26-10-29 €76.15 +0.85% 3,096,724
26-10-28 €75.51 +0.48% 2,827,293
26-10-27 €75.15 +0.76% 1,783,437
26-10-26 €74.58 +0.62% 1,802,573
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Sanofi
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
79.74EUR
Average target price
93.35EUR
Spread / Average Target
+17.07%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Sanofi